Company profile: Bio-Rad
1.1 - Company Overview
Company description
- Provider of imaging systems for fast acquisition, chemiluminescence sensitivity, and fluorescent western blot detection; technologies for rapid bispecific antibody prototyping and high-throughput screening; ready-to-use specialty immunoassay controls; bioprocess data analytics tools; chromatography resources for biomolecule purification; and droplet digital PCR for cell line development, genome edit detection, and CNV analysis.
Products and services
- DdPCR Technology: Research-grade droplet digital PCR technology supporting cell line development, genome edit detection, and copy number variation analysis
- ChemiDoc Go Imaging System: Benchtop imaging system engineered for fast image acquisition, high chemiluminescence sensitivity, and fluorescent western blot detection
- Specialty Immunoassay Plus Controls: Clinical-grade, ready-to-use immunoassay controls with clinically relevant analytes and improved stability for reliable laboratory quality control
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bio-Rad
Definigen
HQ: United Kingdom
Website
- Description: Provider of in-vitro liver and metabolic disease models using iPSC technology to generate pre-clinical human data, offering Opti-HEPs for drug efficacy and predictive toxicology screening, phenotypic screening with bioassays, and custom disease model development via CRISPR. Includes models for Alpha-1 Antitrypsin Deficiency, Wilson's Disease (ATP7B), and Glycogen Storage Disease Type 1 Alpha.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Definigen company profile →
Distributed Bio
HQ: United States
Website
- Description: Provider of computational tools, antibody libraries, and an end-to-end antibody discovery and optimization platform for therapeutic programs, integrating target discovery through clinical development to address challenging targets including GPCRs, ion channels, pMHC complexes, condition-specific binders, anti-idiotypes, and broadly neutralizing viral epitopes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Distributed Bio company profile →
Farcast Biosciences
HQ: United States
Website
- Description: Provider of a diagnostic platform that delivers powerful predictions for personalized cancer treatment selection and drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Farcast Biosciences company profile →
VUV Analytics
HQ: United States
Website
- Description: Provider of vacuum ultraviolet optical technologies for use in the life and environmental sciences.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VUV Analytics company profile →
Berkeley Lights
HQ: United States
Website
- Description: Provider of research and development services using micro-droplet technology to change biological processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Berkeley Lights company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bio-Rad
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bio-Rad
2.2 - Growth funds investing in similar companies to Bio-Rad
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bio-Rad
4.2 - Public trading comparable groups for Bio-Rad
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →